Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders.
Tarr PE, Taffé P, Bleiber G, Furrer H, Rotger M, Martinez R, Hirschel B, Battegay M, Weber R, Vernazza P, Bernasconi E, Darioli R, Rickenbach M, Ledergerber B, Telenti A; Swiss HIV Cohort Study.
Tarr PE, et al.
J Infect Dis. 2005 May 1;191(9):1419-26. doi: 10.1086/429295. Epub 2005 Mar 22.
J Infect Dis. 2005.
PMID: 15809899
Free article.